Media – Shadow

ACT – 12 & ACT – 13 successfully cleared Phase II Clinical trial for COVID 19 Treatment

Nutraceuticals successfully cleared Phase II Clinical trial for COVID 19 Treatment

कोव्हिड १९ वर प्रथम उत्तम उपचारासाठी फेज २ क्लिनिकल ट्रायल पास होणारे जीपीलाईफचे अॅक्ट १२ टॅब्लेटस आणि अॅक्ट १३ ड्राय सिरप हे औषध तयार आणि त्याचे वैश्विक व्यापारीकरणाचे सर्व हक्क सॅडो फार्मा व्हेंचर्सकडे.

Gplife Healthcare obtains Phase II Clinical trial permission for treatment of COVID 19 Positive Patients in India

સુરતના વૈજ્ઞાનિકોએ ન્યુટ્રાસ્યુટીકલ પ્રોડક્ટ બનાવી, જેનો હવે કોરોના પોઝિટિવ દર્દીઓ પર પ્રયોગ કરાશે

Gplife Healthcare obtains Phase II Clinical trial permission for treatment of COVID 19 Positive Patients in India http://dlvr.it/RZZznf

Gplife Healthcare obtains Phase II Clinical trial permission for treatment of COVID 19 Positive Patients in India

Shadow In Media

Social Media

News

Shadow Venture for healthy life ... Read more

Most Promising Brands of 2022 by Midday, Shadow Group carries the tag line “Quality By Diversity”... Read more

ACT – 12 & ACT – 13 successfully cleared Phase II Clinical trial for COVID 19 Treatment ...Read more

Nutraceuticals successfully cleared Phase II Clinical trial for COVID 19 Treatment...Read more

कोव्हिड १९ वर प्रथम उत्तम उपचारासाठी फेज २ क्लिनिकल ट्रायल पास होणारे जीपीलाईफचे अॅक्ट १२ टॅब्लेटस आणि अॅक्ट १३ ड्राय सिरप हे...Read more